Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Synonyms
senp1, senp2, sumo protease, senp6, sumo-specific protease, senp7, smt3ip1, sumo protease 1, ulp1 protease, sumo-specific protease 2,
more
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
His6-Smt3-hemagglutinin fusion protein + H2O
?
-
-
-
?
His6-Smt3-Leu-beta-galactosidase + H2O
?
-
-
-
?
His6-Smt3-Met-beta-galactosidase + H2O
?
-
-
-
?
small ubiquitin-like modifier protein + H2O
?
SUMO-GFP fusion substrate + H2O
SUMO + GFP
pH 8.0, 25°C, in the presence of 5 mM 2-mercaptoethanol
-
-
?
SUMO-MMP13 + H2O
?
cleavage occurs only to 60%
-
-
?
SMT3precursor + H2O
?
-
-
-
-
?
SUMO-1 protein + H2O
?
-
-
-
-
?
additional information
?
-
small ubiquitin-like modifier protein + H2O
?
-
Ulp1 catalyzes the proteolytic processing of SUMO to its mature form
-
?
small ubiquitin-like modifier protein + H2O
?
-
-
Ulp1 catalyzes the proteolytic processing of SUMO to its mature form
-
?
SUMO-1 protein + H2O
?
-
-
-
?
SUMO-1 protein + H2O
?
-
-
-
-
?
SUMO-1 protein + H2O
?
Ulp1 catalyzes two essential functions in the SUMO pathway: 1. the processing of full-length SUMO to its mature form and 2. deconjugation of SUMO from target proteins. Ulp1 can proteolyze large folded SUMO-conjugated proteins without altering their structure
-
-
?
SUMO-1 protein + H2O
?
the enzyme plays an essential role in the G2/M phase of the cell cycle
-
-
?
additional information
?
-
Ulp1 liberates poly-Smt3 from a substrate chain. In vitro, Ulp1 is highly active even in very low concentrations. Substrate specificity analysis of immobilized recombinant enzyme, overview
-
-
?
additional information
?
-
-
the NH2-terminal regulatory domain of Ulp1 restricts Ulp1 activity towards certain sumoylated proteins while enabling the cleavage of others, the COOH-terminal catalytic domain of Ulp1 is both necessary and sufficient for the essential function of the protein in cell cycle progression and for Smt3 precursor cleavage
-
-
?
additional information
?
-
-
the enzyme is specifically required for cell cycle progression
-
-
?
additional information
?
-
-
Ulp1 is responsible for both removing SUMO/Smt3 from specific target proteins and for processing precursor SUMO into its conjugation-competent form. Multiple features in the catalytic domain of Ulp1 affect SUMO interactions, analysis of features of Ulp1 required for substrate targeting, structure-function analysis, overview. D451 is required for targeting of sumoylated proteins and the C580S mutation is required for retention of Ulp1 at the septin ring. Kap121-independent SUMO-targeting information resides in the catalytic domain of Ulp1. The Ulp1 Kap121-interacting domain (region 1), the Ulp1 Kap60/Kap95-interacting domain (region 2) and the catalytic domain (region 3) fail to interact with the Smt3-binding domain
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Gu-HCl
500 mM reduces cleavage to 60%, 1 M reduces cleavage to 0%
NaCl
500 mM reduces cleavage to 60%, 1 M reduces cleavage to 30%
Urea
2 M reduces cleavage to 95%, 3 M reduces cleavage to 5%
additional information
there may be a connection between a defect in SUMO-1 conjugation to the PML protein and acute promyelocytic leukemia (ALP). Specific Ulp inhibitors can therefore have therapeutic value for ALP
-
additional information
no inhibitory effects are observed with Triton X100 (1 M), imidazole (300 mM), reduced glutathione (20 mM), maltose (20 mM), glycerol (20% v/v), ethylene glycol (20% v/v), sucrose (20% w/v), ethanol (10% v/v)
-
additional information
-
no inhibitory effects are observed with Triton X100 (1 M), imidazole (300 mM), reduced glutathione (20 mM), maltose (20 mM), glycerol (20% v/v), ethylene glycol (20% v/v), sucrose (20% w/v), ethanol (10% v/v)
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
medicine
there may be a connection between a defect in SUMO-1 conjugation to the PML protein and acute promyelocytic leukemia (ALP). Specific Ulp inhibitors can therefore have therapeutic value for ALP
biotechnology
-
substrate-trapping Ulp1(3)(C580S) interacts robustly with human SUMO1, SUMO2 and SUMO2 chains, making it a potentially useful tool for the analysis and purification of SUMO-modified proteins
molecular biology
-
usage of the targeting and small ubiquitin-like modifier, SUMO, binding properties of Ulp1(3)(C580S) to purify Smt3-modified proteins from cell extracts
synthesis
-
comparison of Ulp1 protease in active upon expression as inclusion bodies and soluble protein. Fusion of the N-terminal selfassembling peptide GFIL8 to Ulp1 increases production of active inclusion bodies in Escherichia coli. Attachment of the N-terminal cellulose-binding module facilitates the immobilization on regenerated amorphous cellulose with a binding capacity up to about 235 mg protein per gram of cellulose. The immobilized soluble Ulp1 maintains about 42% initial cleavage activity with repetitive use, whereas the aggregated Ulp1 loses its cleavage capacity after cleaving the protein substrate once. Crosslinking of inclusion bodies using glutaraldehyde inactivates Ulp1
synthesis
-
immobilization of Ulp1 as a tool for cleavage of the SUMO tag of recombinant proteins. Ulp1 immobilized on N-hydroxysuccinimide-activated Sepharose maintains 95% substrate-cleavage ability and significantly enhanced pH and thermal stability. The immobilized Ulp1 can tolerate 15% (v/v) DMSO and 20% (v/v) ethanol. It can be reused for more than 15 batch reactions with 90% activity retention
synthesis
-
optimization of expression of the catalytic domain. Optimization of cultivation conditions at shake flask results in Ulp1 expression of 195 mg/l in TB medium. Ni-NTA affinity purification of Ulp1 using 0.1% Triton X-100, 0.01mM DTT, 0.02mM EDTA and 1% glycerol leads to a purity of about 95% with a recovery yield of 80% and specific activity of 398600 U/mg. The protease cleaves the SUMO tag even at 1:10,000 enzyme to substrate ratio The in vivo cleavage of SUMO tag via coexpression strategy also results in more than 80% cleavage of SUMO fusion protein
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Li, S.J.; Hochstrasser, M.
A new protease required for cell-cycle progression in yeast
Nature
398
246-251
1999
Saccharomyces cerevisiae (Q02724)
brenda
Mossessova, E.; Lima, C.D.
Ulp1-SUMO crystal structure and genetic analysis reveal conserved interactions and a regulatory element essential for cell growth in yeast
Mol. Cell
5
865-876
2000
Saccharomyces cerevisiae (Q02724), Saccharomyces cerevisiae
brenda
Li, S.J.; Hochstrasser, M.
The Ulp1 SUMO isopeptidase: distinct domains required for viability, nuclear envelope localization, and substrate specificity
J. Cell. Biol.
160
1069-1081
2003
Saccharomyces cerevisiae
brenda
Lima, C.D.
Ulp1 endopeptidase
Handbook of Proteolytic Enzymes (Barrett, A. J. ; Rawlings, N. D. ; Woessner, eds. )
2
1340-1344
2004
Schizosaccharomyces pombe (O42957), Saccharomyces cerevisiae (Q02724)
-
brenda
Malakhov, M.P.; Mattern, M.R.; Malakhova, O.A.; Drinker, M.; Weeks, S.D.; Butt, T.R.
SUMO fusions and SUMO-specific protease for efficient expression and purification of proteins
J. Struct. Funct. Genomics
5
75-86
2004
Saccharomyces cerevisiae (Q02724), Saccharomyces cerevisiae
brenda
Soustelle, C.; Vernis, L.; Freon, K.; Reynaud-Angelin, A.; Chanet, R.; Fabre, F.; Heude, M.
A new Saccharomyces cerevisiae strain with a mutant Smt3-deconjugating Ulp1 protein is affected in DNA replication and requires Srs2 and homologous recombination for its viability
Mol. Cell. Biol.
24
5130-5143
2004
Saccharomyces cerevisiae (Q02724)
brenda
Dobson, M.J.; Pickett, A.J.; Velmurugan, S.; Pinder, J.B.; Barrett, L.A.; Jayaram, M.; Chew, J.S.
The 2 microm plasmid causes cell death in Saccharomyces cerevisiae with a mutation in Ulp1 protease
Mol. Cell. Biol.
25
4299-4310
2005
Saccharomyces cerevisiae (Q02724), Saccharomyces cerevisiae
brenda
Elmore, Z.C.; Donaher, M.; Matson, B.C.; Murphy, H.; Westerbeck, J.W.; Kerscher, O.
Sumo-dependent substrate targeting of the SUMO protease Ulp1
BMC Biol.
9
74
2011
Saccharomyces cerevisiae
brenda
Eckhoff, J.; Dohmen, R.J.
In vitro studies reveal a sequential mode of chain processing by the yeast SUMO-specific protease Ulp2
J. Biol. Chem.
19
12268-12281
2015
Saccharomyces cerevisiae (Q02724)
brenda
Lewicki, M.C.; Srikumar, T.; Johnson, E.; Raught, B.
The S. cerevisiae SUMO stress response is a conjugation-deconjugation cycle that targets the transcription machinery
J. Proteomics
118
39-48
2015
Saccharomyces cerevisiae, Saccharomyces cerevisiae BY4741/2
brenda
Liang, Q.; Huang, Z.; Zhang, Y.; Li, H.
Immobilization of Ulp1 protease on NHS-activated Sepharose a useful tool for cleavage of the SUMO tag of recombinant proteins
Biotechnol. Lett.
39
1025-1031
2017
Saccharomyces cerevisiae
brenda
Babbal, B.; Adivitiya, B.; Mohanty, S.; Khasa, Y.P.
Bioprocess optimization for the overproduction of catalytic domain of ubiquitin-like protease 1 (Ulp1) from S. cerevisiae in E. coli fed-batch culture
Enzyme Microb. Technol.
120
98-109
2019
Saccharomyces cerevisiae
brenda
Jiang, L.; Xiao, W.; Zhou, X.; Wang, W.; Fan, J.
Comparative study of the insoluble and soluble Ulp1 protease constructs as carrier free and dependent protein immobilizates
J. Biosci. Bioeng.
127
23-29
2019
Saccharomyces cerevisiae
brenda
Peek, J.; Harvey, C.; Gray, D.; Rosenberg, D.; Kolla, L.; Levy-Myers, R.; Yin, R.; McMurry, J.; Kerscher, O.
SUMO targeting of a stress-tolerant Ulp1 SUMO protease
PLoS ONE
13
e0191391
2018
Saccharomyces cerevisiae, Kluyveromyces marxianus, Kluyveromyces marxianus BY28356
brenda